Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Infliximab (Remicade®, Remsima®) in serum and plasma.
The solid phase (MTP) is coated by the drug Infliximab. Due to the assay design this test measures the free antibodies which are not bound to Infliximab. Results could be expressed in both qualitative and quantitative manner (nanogram per mililiter-ng/mL).
Legal Status: CE-Mark
Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Remicade® is a trademark of Janssen Biotech, Inc./Merck & Co.
Remsima® is a trademark of CellTrion Inc.